|
|
Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling.
June H. Myklebust
,
Joshua Brody
,
Holbrook E. Kohrt
,
Arne Kolstad
,
Debra K. Czerwinski
et al.
Journal articles
hal-01475956v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Immunomodulating antibodies and drugs for the treatment of hematological malignancies.
Roch Houot
,
Holbrook Kohrt
,
Matthew J. Goldstein
,
Ronald Levy
Journal articles
istex
hal-00744073v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodies.
Holbrook E. Kohrt
,
Roch Houot
,
Matthew J. Goldstein
,
Kipp Weiskopf
,
Ash A. Alizadeh
et al.
Journal articles
hal-00743985v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Targeting immune effector cells to promote antibody-induced cytotoxicity in cancer immunotherapy.
Roch Houot
,
Holbrook E. Kohrt
,
Aurélien Marabelle
,
Ronald Levy
Journal articles
istex
hal-00744044v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Stimulation of natural killer cells with a CD137-specific antibody enhances trastuzumab efficacy in xenotransplant models of breast cancer.
Holbrook E. Kohrt
,
Roch Houot
,
Kipp Weiskopf
,
Matthew J. Goldstein
,
Ferenc Scheeren
et al.
Journal articles
inserm-00869052v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironment.
Ash A. Alizadeh
,
Andrew J. Gentles
,
Alvaro J. Alencar
,
Chih Long Liu
,
Holbrook E. Kohrt
et al.
Journal articles
hal-00743991v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
First-in-Human Study of Utomilumab, a 4-1BB/CD137 Agonist, in Combination with Rituximab in Patients with Follicular and Other CD20 Non-Hodgkin Lymphomas
Ajay K Gopal
,
Ronald Levy
,
Roch Houot
,
Sandip P Patel
,
Leslie Popplewell
et al.
Journal articles
hal-02563360v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Targeting CD137 enhances the efficacy of cetuximab.
Holbrook E Kohrt
,
a Dimitrios Colevas
,
Roch Houot
,
Kipp Weiskopf
,
Matthew J Goldstein
et al.
Journal articles
hal-01021651v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Could anti-CD20 therapy jeopardise the efficacy of a SARS-CoV-2 vaccine?
Roch Houot
,
Ronald Levy
,
Guillaume Cartron
,
Philippe Armand
Journal articles
hal-02929021v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Urelumab alone or in combination with rituximab in patients with relapsed or refractory B-cell lymphoma
John Timmerman
,
Charles Herbaux
,
Vincent Ribrag
,
Andrew D. Zelenetz
,
Roch Houot
et al.
Journal articles
hal-02798009v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|